Mekinist is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Trametinib Dimethyl Sulfoxide.
| Product ID | 0078-1112_161c037d-f57b-4ee7-b508-796bde819102 |
| NDC | 0078-1112 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mekinist |
| Generic Name | Trametinib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-03-17 |
| Marketing Category | NDA / |
| Application Number | NDA204114 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | TRAMETINIB DIMETHYL SULFOXIDE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-12-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0666 | Mekinist | trametinib |
| 0078-0668 | Mekinist | trametinib |
| 0078-1105 | Mekinist | trametinib |
| 0078-1112 | Mekinist | trametinib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() MEKINIST 85399275 4448207 Live/Registered |
NOVARTIS PHARMA AG 2011-08-16 |